| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
*
Division of Rheumatology and Clinical Immunogenetics and
Division of Medical Genetics, Department of Internal Medicine, University of Texas Medical School, Houston, TX 77030;
Human Genetics Center, University of Texas School of Public Health, Houston, TX 77030;
Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA 15261; and
¶ Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada
The pathogenesis of systemic sclerosis (SSc) involves complex interactions between activated fibroblasts eventually leading to fibrosis, and impaired immune tolerance characterized by a variety of circulating SSc-specific autoantibodies. The expression of autoantigens in fibroblasts, a key target tissue in SSc, may play an important role in this process. To obtain a global view of this process, we examined gene expression profiles of SSc dermal fibroblasts using cDNA microarrays. The results show that dermal fibroblasts from SSc patients obtained from either affected or unaffected skin displayed a characteristic pattern of increased SSc autoantigen gene expression compared with that from normal controls. In particular, fibrillarin (p = 0.028), centromeric protein B (p = 0.01), centromeric autoantigen P27 (p = 0.042), and RNA polymerase II (220 kDa; p = 0.02) were significantly overexpressed in SSc fibroblasts. Quantitative RT-PCR confirmed overexpression of these autoantigens and also revealed increased levels of DNA topoisomerase I transcripts in SSc fibroblasts compared with normal control fibroblasts (p = 0.0318). The polymyositis/scleroderma autoantigen gene was overexpressed in some SSc patients (p = 0.09). To examine the specificity of these overexpressed autoantigen genes for SSc and its tissue specificity for fibroblasts, cDNA microarrays of dermal fibroblasts from patients with eosinophilic fasciitis and scleromyxedema were studied as well as PBMC and muscle biopsies from SSc patients. None of these tissues showed significant alterations in gene expression of SSc-specific autoantigens. Therefore, SSc-associated autoantigen genes are selectively overexpressed in SSc dermal fibroblasts, a major tissue involved in disease pathogenesis.
This article has been cited by other articles:
|
|
 |
|
  W. Ning, Y. Dong, J. Sun, C. Li, M. A. Matthay, C. A. Feghali-Bostwick, and A. M. K. Choi Cigarette Smoke Stimulates Matrix Metalloproteinase-2 Activity via EGR-1 in Human Lung Fibroblasts Am. J. Respir. Cell Mol. Biol., April 1, 2007; 36(4): 480 - 490. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Zhou, F. K. Tan, D. M. Milewicz, X. Guo, C. A. Bona, and F. C. Arnett Autoantibodies to Fibrillin-1 Activate Normal Human Fibroblasts in Culture through the TGF-{beta} Pathway to Recapitulate the "Scleroderma Phenotype" J. Immunol., October 1, 2005; 175(7): 4555 - 4560. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T Bohgaki, Y Amasaki, N Nishimura, M Bohgaki, Y Yamashita, M Nishio, K-i Sawada, S Jodo, T Atsumi, and T Koike Up regulated expression of tumour necrosis factor {alpha} converting enzyme in peripheral monocytes of patients with early systemic sclerosis Ann Rheum Dis, August 1, 2005; 64(8): 1165 - 1173. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. P. Denton, G. E. Lindahl, K. Khan, X. Shiwen, V. H. Ong, N. J. Gaspar, K. Lazaridis, D. R. Edwards, A. Leask, M. Eastwood, et al. Activation of Key Profibrotic Mechanisms in Transgenic Fibroblasts Expressing Kinase-deficient Type II Transforming Growth Factor-{beta} Receptor (T{beta}RII{Delta}k) J. Biol. Chem., April 22, 2005; 280(16): 16053 - 16065. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Chapuy-Regaud, M. Sebbag, D. Baeten, C. Clavel, C. Foulquier, F. De Keyser, and G. Serre Fibrin Deimination in Synovial Tissue Is Not Specific for Rheumatoid Arthritis but Commonly Occurs during Synovitides J. Immunol., April 15, 2005; 174(8): 5057 - 5064. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Lagan, P. Pantelidis, E. A. Renzoni, C. Fonseca, P. Beirne, A. B. Taegtmeyer, C. P. Denton, C. M. Black, A. U. Wells, R. M. du Bois, et al. Single-nucleotide polymorphisms in the SPARC gene are not associated with susceptibility to scleroderma Rheumatology, February 1, 2005; 44(2): 197 - 201. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Ning, C.-J. Li, N. Kaminski, C. A. Feghali-Bostwick, S. M. Alber, Y. P. Di, S. L. Otterbein, R. Song, S. Hayashi, Z. Zhou, et al. Comprehensive gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive pulmonary disease PNAS, October 12, 2004; 101(41): 14895 - 14900. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Yasuoka, H. Ihn, T. A. Medsger Jr, M. Hirakata, Y. Kawakami, Y. Ikeda, and M. Kuwana A Novel Protein Highly Expressed in Testis Is Overexpressed in Systemic Sclerosis Fibroblasts and Targeted by Autoantibodies J. Immunol., December 15, 2003; 171(12): 6883 - 6890. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Whitfield, D. R. Finlay, J. I. Murray, O. G. Troyanskaya, J.-T. Chi, A. Pergamenschikov, T. H. McCalmont, P. O. Brown, D. Botstein, and M. K. Connolly Systemic and cell type-specific gene expression patterns in scleroderma skin PNAS, October 14, 2003; 100(21): 12319 - 12324. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
